Characteristics of prospective participants and participants in a SARS-CoV-2 vaccination trial (phase I-III): demographics, motivation, attitudes to risk and new technologies
- Conditions
- Covid-19
- Registration Number
- DRKS00025242
- Lead Sponsor
- Tropeninstitut am LMU Klinikum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Definition of Participant (Phase I and Phase II/III): Administration of the investigational product/placebo on day 1 of the vaccination study.
Definition of Screen Failure (Phase I and Phase II/III): Exclusion during screening at the trial site.
Definition of Interested Person: Expression of interest in participation in vaccination study and provisioning of e-mail address. No invitation to screening.
Inclusion criterion for online questionnaire: Belonging to one of the above-mentioned groups as well as completion and sending of the questionnaire.
Exclusion Criteria
Obviously incorrect/inconsistent completion of the questionnaire
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Significant differences and correlations in demographics, motivation, and attitudes towards risk, communication and technologies both within and across collectives.
- Secondary Outcome Measures
Name Time Method Correlation of the participants' risk behaviour with their self-assessment and comparison of the self-assessment with the total population.<br>Checking the consistency of the stated motivation. Evaluation of the correlation between altruistic motivation and altruistic action.